"MIATA"-minimal information about T cell assays.

Détails

Ressource 1Télécharger: 19833080_Postprint.pdf (375.14 [Ko])
Etat: Public
Version: de l'auteur⸱e
ID Serval
serval:BIB_07A00768009A
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Lettre (letter): communication adressée à l'éditeur.
Collection
Publications
Institution
Titre
"MIATA"-minimal information about T cell assays.
Périodique
Immunity
Auteur⸱e⸱s
Janetzki S., Britten C.M., Kalos M., Levitsky H.I., Maecker H.T., Melief C.J., Old L.J., Romero P., Hoos A., Davis M.M.
ISSN
1097-4180 ([electronic])
Statut éditorial
Publié
Date de publication
2009
Peer-reviewed
Oui
Volume
31
Numéro
4
Pages
527-528
Langue
anglais
Notes
Publication types: Letter
Résumé
Immunotherapy, especially therapeutic vaccination, has a great deal of potential in the treatment of cancer and certain infectious diseases such as HIV (Allison et al., 2006; Fauci et al., 2008; Feldmann and Steinman, 2005). Numerous vaccine candidates have been tested in patients with a variety of tumor types and chronic viral diseases. Often, the best way to assess the clinical potential of these vaccines is to monitor the induced T cell response, and yet there are currently no standards for reporting these results. This letter is an effort to address this problem.
Mots-clé
Cancer Vaccines/immunology, Cancer Vaccines/therapeutic use, Humans, Immunoassay/standards, Immunotherapy, Monitoring, Immunologic/standards, Neoplasms/therapy, Practice Guidelines as Topic/standards, T-Lymphocytes/immunology, Viral Vaccines/immunology, Viral Vaccines/therapeutic use, Virus Diseases/therapy
Pubmed
Web of science
Open Access
Oui
Création de la notice
04/01/2010 15:58
Dernière modification de la notice
20/08/2019 12:30
Données d'usage